Edition:
United States

Ophthotech Corp (OPHT.OQ)

OPHT.OQ on NASDAQ Stock Exchange Global Select Market

2.28USD
15 Oct 2018
Change (% chg)

-- (--)
Prev Close
$2.28
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
66,126
52-wk High
$4.49
52-wk Low
$2.25

Chart for

About

Ophthotech Corporation is a biopharmaceutical company. The Company is engaged in the development of therapeutics to treat ophthalmic diseases, with a focus on diseases of the back of the eye. Its primary focus is developing therapeutics for age-related macular degeneration (AMD), which is a disorder of the central portion of the... (more)

Overall

Beta: 1.23
Market Cap(Mil.): $85.07
Shares Outstanding(Mil.): 36.20
Dividend: --
Yield (%): --

Financials

  OPHT.OQ Industry Sector
P/E (TTM): 0.55 119.85 32.14
EPS (TTM): 4.25 -- --
ROI: 96.17 1.96 12.83
ROE: -- 1.12 14.95

BRIEF-Ophthotech Reports Q1 Loss Per Share Of $0.36

* OPHTHOTECH REPORTS FIRST QUARTER 2018 FINANCIAL AND OPERATING RESULTS

May 09 2018

BRIEF-Ophthotech Completes Patient Recruitment In A Mid-Stage Trial Of Its Eye Drug Zimura

* OPHTHOTECH COMPLETES PATIENT RECRUITMENT IN THE PHASE 2A CLINICAL TRIAL OF ZIMURA® IN COMBINATION WITH ANTI-VEGF THERAPY IN WET AGE-RELATED MACULAR DEGENERATION

May 01 2018

Earnings vs. Estimates